Exane Derivatives Cerence Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cerence Inc. stock. As of the latest transaction made, Exane Derivatives holds 31 shares of CRNC stock, worth $94. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 1,550
98.0%
Holding current value
$94
Previous $55,000
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CRNC
# of Institutions
200Shares Held
37.6MCall Options Held
231KPut Options Held
1.58M-
Vanguard Group Inc Valley Forge, PA3.98MShares$12.2 Million0.0% of portfolio
-
American Capital Management Inc New York, NY3.88MShares$11.9 Million0.37% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$10.1 Million0.0% of portfolio
-
First Trust Advisors LP Wheaton, IL2.68MShares$8.2 Million0.01% of portfolio
-
Paradigm Capital Management Inc2.24MShares$6.86 Million0.29% of portfolio
About Cerence Inc.
- Ticker CRNC
- Exchange NASDAQ
- Sector Technology
- Industry Software—Application
- Shares Outstandng 39,313,000
- Market Cap $120M
- Description
- Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, ...